1-3 of 3
Peter Fayers
Close
Sort by
Journal Articles

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Clinical Trials & Observations
Anders Waage, Peter Gimsing, Peter Fayers, Niels Abildgaard, Lucia Ahlberg, Bo Björkstrand, Kristina Carlson, Inger Marie Dahl, Karin Forsberg, Nina Gulbrandsen, Einar Haukås, Øyvind Hjertner, Martin Hjorth, Torbjörn Karlsson, Lene Meldgaard Knudsen, Johan Lanng Nielsen, Olle Linder, Ulf-Henrik Mellqvist, Ingerid Nesthus, Jürgen Rolke, Maria Strandberg, Jon Hjalmar Sørbø, Finn Wisløff, Gunnar Juliusson, Ingemar Turesson, for the Nordic Myeloma Study Group
Journal: Blood
Blood (2010) 116 (9): 1405–1412.
https://doi.org/10.1182/blood-2009-08-237974
Published: 2010
Journal Articles

Randomised Study on Prophylactic Pamidronate 30 mg vs. 90 mg in Multiple Myeloma (Nordic Myeloma Study Group).

Peter Gimsing, MD, Kristina Carlson, MD, Peter Fayers, Ingemar Turesson, MD, Finn Wisløff
Journal: Blood
Blood (2007) 110 (11): 533.
https://doi.org/10.1182/blood.V110.11.533.533
Published: 2007
Journal Articles

Melphalan-Prednisone-Thalidomide to Newly Diagnosed Patients with Multiple Myeloma: A Placebo Controlled Randomised Phase 3 Trial.

Anders Waage, MD, Peter Gimsing, MD, Gunnar Juliusson, MD, Ingemar Turesson, MD, Peter Fayers, PhD
Journal: Blood
Blood (2007) 110 (11): 78.
https://doi.org/10.1182/blood.V110.11.78.78
Published: 2007